AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29618485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 80
Study 29618485 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmark technique
Number of subjects: 80
Study 28640529 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 115
Study 28640529 — intervention group
Group type: COMPARATOR
Intervention: Calcineurin inhibitors (CsA)
Number of subjects: 115
Study 25856035 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐second injection duration
Number of subjects: 60
Study 25856035 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐second injection duration and 5‐minute dry cold application
Number of subjects: 60
Study 25856035 — intervention group
Group type: COMPARATOR
Intervention: 10-second injection duration with no dry cold application
Number of subjects: 60
Study 23725491 — intervention group
Group type: EXPERIMENTAL
Intervention: modMA2 (Ti-Zirconium alloy)
Number of subjects: 30
Study 23725491 — intervention group
Group type: EXPERIMENTAL
Intervention: modMA1 (chemically modified hydrophilic acid etched titanium)
Number of subjects: 30
Study 23725491 — intervention group
Group type: EXPERIMENTAL
Intervention: M (hydrophobic machined titanium)
Number of subjects: 30
Study 22145255 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (2 mL)
Number of subjects: 178
Study 22145255 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline (2 mL)
Number of subjects: 178
Study 19095357 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% hypertonic saline injection (0.25ml) into the infra-patellar fat pad
Number of subjects: 7
Study 19095357 — intervention group
Group type: COMPARATOR
Intervention: No pain condition
Number of subjects: 7
Study 19095357 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain condition
Number of subjects: 7
Study 16866137 — intervention group
Group type: EXPERIMENTAL
Intervention: Coartem
Number of subjects: 56
Study 16866137 — intervention group
Group type: COMPARATOR
Intervention: Fansimef
Number of subjects: 56
Study 12633545 — intervention group
Group type: EXPERIMENTAL
Intervention: Atriobiventricular (A-BiV) pacing for 3 months
Number of subjects: 34
Study 12633545 — intervention group
Group type: EXPERIMENTAL
Intervention: Atriobiventricular (A-BiV) pacing for 12 months
Number of subjects: 34
Study 12633545 — intervention group
Group type: COMPARATOR
Intervention: Inactive pacing (ventricular inhibited pacing at 40 beats/min)
Number of subjects: 34
Study 10702449 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% ropivacaine with fentanyl 2 microg/mL
Number of subjects: 50
Study 10702449 — intervention group
Group type: COMPARATOR
Intervention: 0.125% bupivacaine with fentanyl
Number of subjects: 50
Study 9061108 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg morphine intra-articularly + saline intramuscularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg pethidine intra-articularly + saline intramuscularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms fentanyl intra-articularly + saline intramuscularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: COMPARATOR
Intervention: Saline intramuscularly + 1 mg morphine intra-articularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: COMPARATOR
Intervention: Saline intramuscularly + 10 mg pethidine intra-articularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: COMPARATOR
Intervention: Saline intramuscularly + 10 micrograms fentanyl intra-articularly
Number of subjects: 70
Study 9061108 — intervention group
Group type: COMPARATOR
Intervention: Saline intra-articularly + saline intramuscularly (control group)
Number of subjects: 70
Study 8173520 — intervention group
Group type: EXPERIMENTAL
Intervention: Boomerang pillows
Number of subjects: 42
Study 8173520 — intervention group
Group type: COMPARATOR
Intervention: Straight pillows
Number of subjects: 42
Study 8173520 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-Fowler's position
Number of subjects: 42
Study 3594019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aid intervention (fitted for hearing purposes)
Number of subjects: 39
Study 3594019 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (no intervention for 6 weeks)
Number of subjects: 39
Study 3594019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aid use for more than 2 hours daily
Number of subjects: 39
Study 3594019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aid use for less than 2 hours daily
Number of subjects: 39
Study 3594019 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and post-fitting scaling
Number of subjects: 39
Study 31177305 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis and 6 weekly optimized mitomycin C instillations
Number of subjects: 131
Study 31177305 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant cytology
Number of subjects: 131
Study 31177305 — intervention group
Group type: EXPERIMENTAL
Intervention: Current and former smokers
Number of subjects: 131
Study 29050922 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 260
Study 29050922 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic medication (AAD)
Number of subjects: 260
Study 27306420 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone-based lubricant
Number of subjects: 38
Study 27306420 — intervention group
Group type: COMPARATOR
Intervention: Water-based lubricant
Number of subjects: 38
Study 27306420 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lubricants
Number of subjects: 38
Study 26667497 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 0
Study 26667497 — intervention group
Group type: COMPARATOR
Intervention: Intranasal sterile saline (Control)
Number of subjects: 0
Study 23513240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 23513240 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of intraplaque hemorrhage (IPH)
Number of subjects: 73
Study 23513240 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in LRNC
Number of subjects: 73
Study 19875752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 2754
Study 19875752 — intervention group
Group type: EXPERIMENTAL
Intervention: Local treatment strategies
Number of subjects: 2754
Study 19055622 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 212
Study 19055622 — intervention group
Group type: EXPERIMENTAL
Intervention: SP plus amodiaquine (AQSP)
Number of subjects: 212
Study 19055622 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus SP (ASSP)
Number of subjects: 212
Study 19055622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutations at dhps‐437 and dhps‐540
Number of subjects: 212
Study 16540136 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 153
Study 16540136 — intervention group
Group type: COMPARATOR
Intervention: Multi-micronutrient supplementation
Number of subjects: 153
Study 16540136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 14572568 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection of absolute ethanol (group I, n = 42)
Number of subjects: 126
Study 14572568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoclipping (group II, n = 42)
Number of subjects: 126
Study 14572568 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both methods (group III, n = 42)
Number of subjects: 126
Study 11087165 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy
Number of subjects: 0
Study 8747973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal octreotide
Number of subjects: 2
Study 1357894 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg b.i.d. for 10 days
Number of subjects: 19
Study 1357894 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethyl-penicillin 1 g b.i.d. for 10 days
Number of subjects: 19
Study 2436506 — intervention group
Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 147
Study 2436506 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 147
Study 31474530 — intervention group
Group type: EXPERIMENTAL
Intervention: Darco Plantar Lapidus Plating System® (Wright Medical, Memphis, TN)
Number of subjects: 12
Study 31474530 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantar Lapidus Plate® (Arthrex, Naples, FL)
Number of subjects: 12
Study 29643231 — intervention group
Group type: EXPERIMENTAL
Intervention: OCDC (oxidized autologous whole‐tumor cell lysate) administered alone (cohort 1, n = 5)
Number of subjects: 25
Study 29643231 — intervention group
Group type: EXPERIMENTAL
Intervention: OCDC in combination with bevacizumab (cohort 2, n = 10)
Number of subjects: 25
Study 29643231 — intervention group
Group type: EXPERIMENTAL
Intervention: OCDC in combination with bevacizumab plus low‐dose intravenous cyclophosphamide (cohort 3, n = 10)
Number of subjects: 25
Study 27858069 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-gingivitis IgY toothpaste used twice daily for 3 minutes
Number of subjects: 100
Study 27858069 — intervention group
Group type: COMPARATOR
Intervention: None anti-gingivitis IgY toothpaste
Number of subjects: 100
Study 24941838 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligustrazine Hydrochloride (LH) 3 mg/kg intravenously infused and added in CPB priming
Number of subjects: 40
Study 24941838 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 40
Study 23947902 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon nitride ceramic cages
Number of subjects: 100
Study 23947902 — intervention group
Group type: COMPARATOR
Intervention: PEEK cages
Number of subjects: 100
Study 19823907 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on a virtual laparoscopic simulator
Number of subjects: 0
Study 19823907 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17917696 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (20 g x d(‐1))
Number of subjects: 11
Study 17917696 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (20 g x d(‐1))
Number of subjects: 11
Study 16025961 — intervention group
Group type: EXPERIMENTAL
Intervention: Quyu Xiaoban capsule (QXC)
Number of subjects: 80
Study 14708338 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite outcomes
Number of subjects: 0
Study 14708338 — intervention group
Group type: EXPERIMENTAL
Intervention: Single primary outcome
Number of subjects: 0
Study 14708338 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 14708338 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 0
Study 10399048 — intervention group
Group type: EXPERIMENTAL
Intervention: Peroral methadone
Number of subjects: 134
Study 10399048 — intervention group
Group type: COMPARATOR
Intervention: Injectable methadone
Number of subjects: 134
Study 10399048 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of health risks
Number of subjects: 134
Study 10399048 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for injection
Number of subjects: 134
Study 8559353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 50
Study 8559353 — intervention group
Group type: COMPARATOR
Intervention: Plasma exchange (PLEX)
Number of subjects: 50
Study 1814297 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 42
Study 1814297 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 42
Study 7049190 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 310
Study 7049190 — intervention group
Group type: COMPARATOR
Intervention: Gefarnate
Number of subjects: 310
Study 30217554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum midwifery care
Number of subjects: 209
Study 30477474 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate adaptations (no wait)
Number of subjects: 60
Study 30477474 — intervention group
Group type: COMPARATOR
Intervention: Usual adaptations (3-4 month wait)
Number of subjects: 60
Study 26865133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% 20 ml
Number of subjects: 30
Study 26865133 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75% 5 ml
Number of subjects: 30
Study 24144551 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology (ortho-k)
Number of subjects: 2
Study 24144551 — intervention group
Group type: COMPARATOR
Intervention: Single vision lenses (SVLs)
Number of subjects: 2
Study 22108393 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia
Number of subjects: 2000
Study 22108393 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 2000
Study 19264567 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical and/or pharmacological prophylaxis
Number of subjects: 0
Study 19264567 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 17125997 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 microg of intrathecal diamorphine
Number of subjects: 120
Study 17125997 — intervention group
Group type: EXPERIMENTAL
Intervention: intrathecal diamorphine (100 microg, 200 microg, or 300 microg)
Number of subjects: 120
Study 17125997 — intervention group
Group type: EXPERIMENTAL
Intervention: intrathecal diamorphine
Number of subjects: 120
Study 17125997 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study 15970816 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring + fetal pulse oximetry
Number of subjects: 360
Study 15970816 — intervention group
Group type: COMPARATOR
Intervention: Monitoring alone
Number of subjects: 360
Study 11923550 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 18
Study 11923550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9706852 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brushes (IDB)
Number of subjects: 26
Study 9706852 — intervention group
Group type: COMPARATOR
Intervention: Dental floss (DF)
Number of subjects: 26
Study 7636515 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum interview data
Number of subjects: 367
Study 7636515 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetric records
Number of subjects: 367
Study 2244769 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion clinic model
Number of subjects: 1224
Study 2244769 — intervention group
Group type: COMPARATOR
Intervention: Physician-oriented model
Number of subjects: 1224
Study 2244769 — intervention group
Group type: COMPARATOR
Intervention: Patient education model
Number of subjects: 1224
Study 2244769 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1224
Study 283002 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste A (active ingredient)
Number of subjects: 60
Study 283002 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste B (active ingredient)
Number of subjects: 60
Study 283002 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 60
Study 30802558 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifarotene 50 μg/g cream
Number of subjects: 0
Study 30802558 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 28662074 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice diet
Number of subjects: 28
Study 28662074 — intervention group
Group type: COMPARATOR
Intervention: White rice diet
Number of subjects: 28
Study 26388539 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Behavioral Therapy (ICBT) plus Standard Care (SC)
Number of subjects: 126
Study 26388539 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Addiction Counseling (IAC) plus Standard Care (SC)
Number of subjects: 126
Study 26388539 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC) alone
Number of subjects: 126
Study 26388539 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Assisted Treatment (MAT)
Number of subjects: 126
Study 23824248 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐HT2A receptor blockade with ketanserin
Number of subjects: 0
Study 23824248 — intervention group
Group type: COMPARATOR
Intervention: Control session (no ketanserin)
Number of subjects: 0
Study 21307305 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 21307305 — intervention group
Group type: COMPARATOR
Intervention: Serum salicylate levels
Number of subjects: 0
Study 18848957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine alone (0.2 mg/kg, IV)
Number of subjects: 7
Study 18848957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (0.2 mg/kg, IV) + Nalbuphine (5 mg/70 kg, IV)
Number of subjects: 7
Study 18848957 — intervention group
Group type: COMPARATOR
Intervention: Cocaine alone
Number of subjects: 7
Study 18048942 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration group
Number of subjects: 43
Study 18048942 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-without-vibration group
Number of subjects: 43
Study 18048942 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 16298773 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mg sustained-release melatonin
Number of subjects: 36
Study 16298773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 11803097 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure of peritoneum
Number of subjects: 60
Study 11803097 — intervention group
Group type: COMPARATOR
Intervention: Nonclosure of peritoneum
Number of subjects: 60
Study 10992868 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified drug delivery system (study group)
Number of subjects: 0
Study 10992868 — intervention group
Group type: COMPARATOR
Intervention: Existing drug delivery system (control group)
Number of subjects: 0
Study 7662481 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (20 ml of 1% lidocaine)
Number of subjects: 52
Study 7662481 — intervention group
Group type: COMPARATOR
Intervention: Pethidine/diazepam (intravenous)
Number of subjects: 52
Study 2526706 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg flunarizine for 3 months
Number of subjects: 0
Study 2526706 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 0
Study 825134 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) small particles
Number of subjects: 5
Study 825134 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) intermediate particles
Number of subjects: 5
Study 825134 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) large particles
Number of subjects: 5
Study 31033637 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention
Number of subjects: 344
Study 27012857 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathy prime (line drawing depicting two individuals pointing in the same direction)
Number of subjects: 60
Study 27012857 — intervention group
Group type: COMPARATOR
Intervention: Non-empathy prime (line drawing depicting two individuals pointing in opposite directions)
Number of subjects: 60
Study 26121746 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg daily taken orally for 1 week)
Number of subjects: 56
Study 26121746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 24171699 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise followed by prescription of physical activity
Number of subjects: 216
Study 24171699 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach followed by prescription of physical activity
Number of subjects: 216
Study 24171699 — intervention group
Group type: COMPARATOR
Intervention: Prescription of physical activity alone without neck-specific exercises
Number of subjects: 216
Study 21424150 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled gastroduodenostomy
Number of subjects: 197
Study 21424150 — intervention group
Group type: COMPARATOR
Intervention: Handsewn gastroduodenostomy
Number of subjects: 197
Study 18498882 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen tablets
Number of subjects: 39
Study 18498882 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen liquigels
Number of subjects: 39
Study 18498882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 18498882 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 39
Study 18498882 — intervention group
Group type: EXPERIMENTAL
Intervention: Obturation
Number of subjects: 39
Study 16837545 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival autograft
Number of subjects: 287
Study 16837545 — intervention group
Group type: COMPARATOR
Intervention: Amniotic membrane transplantation
Number of subjects: 287
Study 12851622 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro stent II (M)
Number of subjects: 925
Study 12851622 — intervention group
Group type: EXPERIMENTAL
Intervention: Sito (S)
Number of subjects: 925
Study 12851622 — intervention group
Group type: EXPERIMENTAL
Intervention: Pura Vario (PV)
Number of subjects: 925
Study 12851622 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflow (ID)
Number of subjects: 925
Study 12851622 — intervention group
Group type: COMPARATOR
Intervention: Early adverse events (all stent types)
Number of subjects: 925
Study 10822392 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat exposure at 33 degrees C and 50-55% relative humidity for 1 hour
Number of subjects: 14
Study 10822392 — intervention group
Group type: COMPARATOR
Intervention: Ambient temperature of 25 degrees C and 50% relative humidity for 1 hour (baseline)
Number of subjects: 14
Study 8777252 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy including cisplatin; specific dosage and duration not mentioned.
Number of subjects: 0
Study 8777252 — intervention group
Group type: COMPARATOR
Intervention: Local treatment alone; specific details not mentioned.
Number of subjects: 0
Study 1795048 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MR)
Number of subjects: 15